Tsurubuchi Takao, Miki Shunichiro, Kino Hiroyoshi, Akutsu Hiroyoshi, Aiyama Hitoshi, Matsuda Masahide, Sakamoto Noriaki, Ishikawa Eiichi
Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Department of Neurosurgery, Ibaraki Clinical Education and Training Center, Institute of Medicine, University of Tsukuba, Japan.
J Neurosurg Case Lessons. 2025 Sep 15;10(11). doi: 10.3171/CASE25459.
Patients with von Hippel-Lindau disease (VHLD) often have multiple intramedullary tumors, including hemangioblastoma and rarely intramedullary metastatic renal cell carcinoma (RCC). However, the incidence of intramedullary metastatic clear-cell RCC (CCRCC) comorbid with hemangioblastoma is not clear.
The authors report a rare case of intramedullary metastatic CCRCC comorbid with multiple hemangioblastomas in a patient with VHLD. The preoperative differential diagnosis by MRI was difficult. She underwent three surgical removals. After removal of hemangioblastoma at the first surgery, the juxtaposed tumor grew fast during 3 years. Moreover, 4 years after the second surgery, one of the two adjacent increasing tumors grew faster than another. The pathological diagnoses of both fast-growing tumors were intramedullary metastatic CCRCC, not hemangioblastoma. This patient has no neurological deficits and is now being followed up as an outpatient without any further treatment.
Although a rare metastatic intramedullary CCRCC is difficult to differentiate from comorbid hemangioblastomas in patients with VHLD, it is important to note that the tumor growth rate differs between hemangioblastoma and metastatic CCRCC, which can be followed using sequential MRI. Care must be taken not to dismiss the timing of the removal of metastatic intramedullary tumors. https://thejns.org/doi/10.3171/CASE25459.
冯·希佩尔-林道病(VHLD)患者常患有多个髓内肿瘤,包括血管母细胞瘤,很少有髓内转移性肾细胞癌(RCC)。然而,与血管母细胞瘤并存的髓内转移性透明细胞肾细胞癌(CCRCC)的发生率尚不清楚。
作者报告了1例VHLD患者罕见的髓内转移性CCRCC与多个血管母细胞瘤并存的病例。术前通过MRI进行鉴别诊断困难。患者接受了3次手术切除。第一次手术切除血管母细胞瘤后,相邻肿瘤在3年内快速生长。此外,第二次手术4年后,两个相邻增大的肿瘤中有1个比另一个生长得更快。两个快速生长肿瘤的病理诊断均为髓内转移性CCRCC,而非血管母细胞瘤。该患者无神经功能缺损,目前作为门诊患者接受随访,未进行任何进一步治疗。
尽管VHLD患者中罕见的转移性髓内CCRCC难以与并存的血管母细胞瘤相鉴别,但重要的是要注意血管母细胞瘤和转移性CCRCC的肿瘤生长速度不同,可以通过连续MRI进行随访。必须注意不要忽视切除转移性髓内肿瘤的时机。https://thejns.org/doi/10.3171/CASE25459